查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1776201

合成橡膠幫浦的全球市場:洞察，競爭情形，市場預測:2032年

Elastomeric Pump - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2024年，彈性體幫浦市場規模達6.6339億美元。預計2025年至2032年期間，該市場將以6.72%的複合年增長率成長，到2032年將達到11.0914億美元。彈性體幫浦的需求受多種關鍵因素驅動，其中包括癌症、糖尿病和神經系統疾病等慢性疾病的發生率不斷上升。此外，全球外科手術數量的增加也增加了患者對輸液治療的需求。此外，產品開發領域的持續技術進步也提高了這些設備的有效性和便利性。這些因素共同為2025年至2032年彈性幫浦市場穩定成長奠定了堅實的基礎。

彈性幫浦市場動態：

根據GLOBOCAN數據（2023年），2022年將報告約2000萬例新增癌症病例，預計到2045年這一數字將增至3260萬例。癌症患者數量的成長推動了對彈性化療輸液幫浦的需求。這些幫浦通常是一次性使用的，經過單獨校準以確保準確一致的藥物輸送，使其成為門診腫瘤治療的必需品。

同樣，全球糖尿病負擔也迅速增加。根據國際糖尿病聯盟 (2023) 的數據，2021 年約有 5.37 億成年人（20-79 歲）患有糖尿病。預計到 2030 年，這一數字將增至 6.43 億，到 2045 年將增至 7.83 億。彈性幫浦在這一領域發揮重要作用，透過確保持續且準確的胰島素輸送，幫助在門診和家庭環境中維持更好的血糖控制。

此外，傳染病負擔仍是一個主要問題。根據世界衛生組織 (2024) 的數據，估計到 2023 年，愛滋病毒感染者人數將達到 3,990 萬人，其中包括 140 萬名兒童（0-14 歲）和 3,860 萬名成年人（15 歲及以上）。

此外，根據世界衛生組織 (WHO) (2024) 提供的數據，預計到 2023 年，全球將有 1,080 萬人罹患結核病，其中包括 600 萬名男性、360 萬名女性和 130 萬名兒童。愛滋病毒患者和類似慢性感染患者通常需要長期靜脈注射抗生素治療，而彈性泵可以透過持續輸注有效地進行給藥，尤其是在門診和家庭護理環境中。

慢性疼痛管理也是一個主要的應用領域。透過彈性幫浦注射局部麻醉劑通常用於術後和慢性疼痛管理。根據歐洲疼痛聯合會 (2023) 的數據，歐洲約有 1.5 億人患有慢性疼痛。這些幫浦提供了一種有效的非電子解決方案，可長期給藥，無需住院。

此外，根據世界衛生組織 (WHO) (2024) 的數據，2022 年約有 25 億成年人（18 歲及以上）超重。其中，8.9 億人患有肥胖症。此外，肥胖患者經常接受減重手術和其他需要術後疼痛管理的手術，而彈性幫浦通常用於持續輸送止痛藥。

此外，全球外科手術的增加預計將進一步刺激對彈性幫浦的需求。根據歐盟 (2023) 提供的數據，2022 年歐盟約有 110 萬例剖腹產。這些幫浦將液體止痛藥直接輸送到手術部位，有助於控制術後疼痛。例如，根據加拿大薩斯喀徹溫省政府2024年5月發布的數據，2023-24財年將進行約95,700例手術，較上一財年大幅增加。隨著手術數量的持續成長，預計彈性幫浦市場也將隨之成長。

然而，彈性泵的局限性和挑戰，以及嚴格的設備審批監管要求，是可能限制彈性泵市場成長的關鍵限制因素。

彈性幫浦市場區隔分析

彈性幫浦市場：依產品類型（連續速度彈性輸液幫浦、變速彈性輸液幫浦、兩者兼有）、給藥途徑（靜脈、皮下、硬膜外、其他）、適應症（疼痛管理、抗生素治療、化療、其他）、最終用戶（醫院、門診手術中心、家庭醫療保健、其他）和地區（北美、歐洲、亞太地區、其他）

按產品類型劃分的彈性幫浦市場中，連續速度彈性輸液幫浦類別預計將在 2024 年佔據最大的市場佔有率。這一增長主要得益於慢性病盛行率的上升，以及連續速度彈性泵在治療和管理此類疾病方面所提供的多功能性和臨床益處。

連續流速的主要優點之一彈性幫浦的優點在於其能夠以預定的恆定流速輸送藥物，從而保持血漿中藥物濃度的穩定性。這使得它們非常適合那些需要維持穩態藥物濃度的治療，例如抗生素、止痛藥和化療藥物的給藥。例如，彈性幫浦廣泛應用於門診腸外抗生素治療 (OPAT)，因為它們可以實現便攜式、非電子輸液，無需外部電源或複雜的管路系統。由 Progressive Medical, Inc. 開發的 SMARTeZ® 拋棄式彈性幫浦就是一個典型的例子，它專為間歇性和連續性抗生素輸液以及常規輸液治療而設計。

彈性幫浦設計的技術進步顯著提高了其易用性、耐用性和安全性。這些創新使得泵浦的藥物穩定性和保質期提高，使其能夠在不影響性能的情況下進行冷藏或冷凍。這些先進設備的一個關鍵優勢在於其內建預設流量，從而最大限度地降低了誤用風險，而誤用是電子輸液泵常見的問題。

此外，持續作用彈性幫浦透過內部彈性球囊自行供電，無需電池或外部電源。此外，其易於維護的設計降低了機械故障的可能性，並提高了可靠性。這些特性，加上其便攜性和易用性，使這些幫浦適用於各種臨床環境。

這些因素預計將推動細分市場的發展，並最終擴大全球彈性泵市場。

預計北美將主導整個彈性幫浦市場：

預計到2024年，北美將佔據彈性幫浦市場的最大佔有率，這主要得益於幾個關鍵因素。該地區的主導地位主要歸功於慢性病盛行率的上升、高度發展的醫療基礎設施以及主要市場參與者的強大影響力。綜合起來，這些因素使北美成為全球彈性泵市場的領先市場。

根據國際癌症研究機構 (2025) 的數據，預計美國新增癌症病例數將從 2022 年的 2,380,189 例大幅增加到 2045 年的 3,380,124 例。其中，白血病新增病例預計將從 2022 年的 63,100 例增加到 2045 年的 88,600 例。同樣，根據加拿大癌症協會 (2024) 的數據，加拿大將有超過 6,600 人被診斷出患有白血病。癌症治療通常需要持續進行化療、標靶治療和免疫治療，因此彈性輸液幫浦成為癌症治療中不可或缺的工具。

根據美國心臟協會 (2024) 的數據，超過 2,930 萬成年人被診斷出患有糖尿病，但估計仍有 970 萬人未確診。此外，截至 2021 年，據報導有 1.159 億美國人處於糖尿病前期。彈性幫浦在胰島素治療中發揮關鍵作用，它能夠準確、持續地傳遞維持穩定血糖水平所需的劑量，尤其對於需要強化胰島素治療的患者而言。

此外，根據美國疾病管制與預防中心 (2023) 的數據，到 2022 年，約有 20.9% 的成年人（5,160 萬人）將遭受慢性疼痛的困擾。其中，6.9%（1,710 萬人）患有嚴重的慢性疼痛，嚴重限制了他們的日常活動。彈性幫浦通常用於持續輸注止痛藥物，如今正越來越多地被用作疼痛管理策略，尤其是對於長期忍受非癌性疼痛的患者。

此外，根據美國衛生與公共服務部 (2023) 的數據，每年約有 2,300 萬美國人前往醫生辦公室或診所就診，尋求感染治療。

除了日益加重的疾病負擔外，北美還受益於先進的醫療保健基礎設施，這支持了先進輸液技術的廣泛應用。主要醫療器材製造商和關鍵市場參與者的存在進一步鞏固了該地區在全球彈性幫浦市場的地位。

這些因素——慢性病盛行率的上升、強勁的臨床需求以及強大的醫療保健基礎設施——預計將在預測期內顯著推動北美彈性泵市場的成長。

彈性幫浦市場的主要參與者

彈性幫浦市場的主要參與者包括 B.Braun Melsungen AG、Baxter、Nipro Corporation、DAIKEN MEDICAL CO、Gamastech Innovative Infusion Systems、Vikymed Italia srl、PAJUNK、Ace Medical、McKesson Corporation、MULTIMEDICAL S.r.l.、Progive Medical, Medical, N.F. SRL、FLOWONIX MEDICAL INC.、Smiths Group plc、Fresenius SE & Co. KGaA、Avanos Medical, Inc. 和 Intera Oncology。

彈性體幫浦市場的最新發展：

  • 2024年5月，Arecor Therapeutics plc宣布與美敦力公司合作研發一種新型高濃度、熱穩定性胰島素，用於下一代胰島素幫浦。透過此次合作，兩家公司將在胰島素治療領域取得進展，透過提供減少胰島素幫浦維護介入需求的胰島素來改善患者照護。這可能會擴大醫生的受益，並顯著節省醫療成本。

合成橡膠幫浦市場調查報告書主要的要點

  • 目前彈性幫浦市場規模分析（2024 年）及八年（2025-2032 年）市場預測
  • 過去三年主要產品/技術開發、併購、合作及合資企業
  • 主導彈性幫浦市場的主要公司
  • 彈性幫浦市場競爭對手面臨的各種機會
  • 2024 年的主要細分市場及其 2032 年的表現
  • 目前彈性幫浦市場 彈性幫浦市場表現最佳的地區和國家
  • 企業應關注的彈性幫浦市場未來成長機會的地區和國家

合成橡膠幫浦市場常被詢問的問題

1.彈性體幫浦

  • 彈性體泵，也稱為球囊泵或彈性體輸液泵，是一種非電子一次性醫療器械，用於在一段時間內向患者輸送定量藥物。

2. 彈性體幫浦市場

  • 預計2024年彈性體幫浦市場規模將達到6.6339億美元，2025年至2032年的複合年增長率為6.72%，到2032年將達到11.0914億美元。

3. 彈性體幫浦市場推動因素

  • 彈性體幫浦的需求受多種關鍵因素驅動，其中包括癌症、糖尿病和神經系統疾病等慢性疾病的發生率不斷上升。此外，家庭醫療保健也日益受到青睞，這些幫浦可幫助患者在家中接受輸液治療。此外，產品開發領域的技術進步也不斷提升這些設備的效能和便利性。這些因素共同為彈性幫浦市場在2025年至2032年期間的穩健成長奠定了堅實的基礎。

4.彈性體幫浦市場的主要公司

  • 彈性體幫浦市場的主要參與者包括 B.Braun Melsungen AG、Baxter、Nipro Corporation、DAIKEN MEDICAL CO、Gamastech Innovative Infusion Systems、Vikymed Italia srl、PAJUNK、Ace Medical、McKesson Corporation、MULTIMEDICAL S.r.l.、Progive Medicalr. SRL、FLOWONIX MEDICAL INC.、Smiths Group plc、Fresenius SE & Co. KGaA、Avanos Medical, Inc. 和 Intera Oncology。

5.彈性體幫浦市佔率最大的地區

  • 預計到2024年，北美將佔據彈性體幫浦市場的最大佔有率，這主要得益於幾個關鍵因素。該地區的主導地位主要歸功於慢性病盛行率的上升、高度發展的醫療保健基礎設施以及主要市場參與者的強大影響力。綜合起來，這些因素使北美成為全球彈性體幫浦市場的領先市場。

目錄

第1章 合成橡膠幫浦市場報告的簡介

第2章 合成橡膠幫浦市場摘要整理

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 合成橡膠幫浦市場主要原因分析

  • 彈性體幫浦市場推動因素
    • 慢性病發生率上升
    • 醫療保健領域外科手術數量增加
    • 產品開發技術進步
  • 彈性體幫浦市場限制與挑戰
    • 彈性幫浦的限制與挑戰
    • 嚴格的設備審批監理要求
  • 彈性泵的市場機遇
    • 改進產品設計，提高藥物輸送精度
    • 家用彈性泵的擴張

第6章 合成橡膠幫浦市場波特的五力分析

第7章 合成橡膠幫浦市場評估

  • 各產品類型
    • 常用速度合成橡膠輸液幫浦
    • 可變比率合成橡膠輸液幫浦
    • 雙方
  • 各給藥途徑
    • 靜脈內
    • 皮下
    • 硬膜外麻醉
    • 其他
  • 各適應症
    • 疼痛管理
    • 抗生素療法
    • 化療
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
    • 居家照護
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 合成橡膠幫浦市場企業與產品簡介

  • B.Braun Melsungen AG
  • Baxter
  • Nipro Corporation
  • DAIKEN MEDICAL CO., LTD.
  • Gamastech Innovative Infusion Systems
  • Vikymed Italia srl
  • PAJUNK
  • Ace Medical
  • McKesson Corporation
  • MULTIMEDICAL S.r.l.
  • Progressive Medical, Inc.
  • Vygon Group
  • Promecon GmbH
  • Preferred Medical
  • Adriamed SRL
  • FLOWONIX MEDICAL INC.
  • Smiths Group plc
  • Fresenius SE & Co. KGaA.
  • Avanos Medical, Inc.
  • Intera Oncology

第9章 KOL的見解

第10章 計劃方法

第11章 關於DelveInsight

第12章 免責聲明和諮詢方式

Product Code: DIMDCL0236

Elastomeric Pump Market by Product Type (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps, and Both), Route of Administration (Intravenous, Subcutaneous, Epidural, and Others), Indication (Pain Management, Antibiotic Therapy, Chemotherapy, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of chronic diseases, increasing surgical procedures, and technological advancements in product development.

The elastomeric pump market was valued at USD 663.39 million in 2024, growing at a CAGR of 6.72% during the forecast period from 2025 to 2032 to reach USD 1,109.14 million by 2032. The demand for elastomeric pumps is growing due to several key factors. These include the increasing prevalence of chronic diseases such as cancer, diabetes, and neurological conditions, and others. The increasing number of surgical procedures performed worldwide also necessitates infusion therapy for patients. Additionally, ongoing technological advancements in product development are enhancing the effectiveness and convenience of these devices. Together, these factors are creating a strong foundation for steady and robust growth in the elastomeric pump market from 2025 to 2032.

Elastomeric Pump Market Dynamics:

According to data from GLOBOCAN (2023), approximately 20 million new cancer cases were reported in 2022, a number projected to rise to 32.6 million by 2045. This increasing cancer burden underscores the rising demand for chemotherapy elastomeric infusion pumps, which are specifically designed to deliver chemotherapy medications. These pumps are typically disposable, single-use devices, individually calibrated for accurate and consistent drug delivery, making them essential in ambulatory oncology care.

Similarly, the global diabetes burden is escalating rapidly. As per the International Diabetes Federation (2023), around 537 million adults (aged 20-79) were living with diabetes in 2021. This number is expected to grow to 643 million by 2030 and 783 million by 2045. Elastomeric pumps play a crucial role in this domain by ensuring continuous and accurate insulin delivery, thereby helping to maintain better glycemic control in outpatient and home settings.

Moreover, the burden of infectious diseases remains a major concern. According to the World Health Organization (2024), an estimated 39.9 million people were living with HIV in 2023, including 1.4 million children (0-14 years) and 38.6 million adults (15+ years).

Additionally, according to the data provided by the World Health Organization (2024), in 2023, an estimated 10.8 million people fell ill with TB worldwide, including 6.0 million men, 3.6 million women, and 1.3 million children. Patients with HIV and similar chronic infections often require long-term intravenous antibiotic therapy, which elastomeric pumps can administer effectively through continuous infusion, particularly in outpatient and home-based care.

Chronic pain management is another major application area. Local anesthetic infusions delivered via elastomeric pumps are frequently used for managing post-operative and chronic pain. According to the European Pain Federation (2023), approximately 150 million people in Europe suffer from chronic pain. These pumps offer an effective, non-electronic solution for delivering pain relief medications over extended periods without the need for hospitalization.

Furthermore, according to data provided by the World Health Organization (2024), in 2022, approximately 2.5 billion adults (18 years and older) were overweight. Of these, 890 million were living with obesity. Additionally, obese patients frequently undergo bariatric surgeries and other procedures that necessitate post-operative pain management, where elastomeric pumps are commonly used to deliver analgesics continuously.

Additionally, the growing number of surgical procedures worldwide is expected to further stimulate demand for elastomeric pumps. According to the data provided by the European Union (2023), there were approximately 1.10 million caesarean sections performed in the EU in 2022. These pumps deliver liquid pain medication directly to the surgical site, helping to manage post-operative pain. For example, data published by the Government of Saskatchewan, Canada, in May 2024 revealed that approximately 95,700 surgeries were performed in the fiscal year 2023-24, representing a notable increase compared to the previous year. As surgical volumes continue to rise, the market for elastomeric pumps is expected to grow in parallel.

However, the limitations and challenges associated with elastomeric pumps and stringent regulatory requirements for device approval, among others, are some of the key constraints that may limit the growth of the elastomeric pump market.

Elastomeric Pump Market Segment Analysis:

Elastomeric Pump Market by Product Type (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps, and Both), Route of Administration (Intravenous, Subcutaneous, Epidural, and Others), Indication (Pain Management, Antibiotic Therapy, Chemotherapy, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the elastomeric pump market, the continuous rate elastomeric infusion pumps category is estimated to account for the largest market share in 2024. This growth is primarily driven by the increasing prevalence of chronic diseases and the versatility and clinical advantages offered by continuous rate elastomeric pumps in the treatment and management of such conditions.

One of the key advantages of continuous rate elastomeric pumps is their ability to deliver medication at a predetermined, consistent flow rate, ensuring stable plasma drug concentrations. This makes them ideal for therapies where maintaining steady-state drug levels is crucial, such as in the administration of antibiotics, analgesics, and chemotherapy agents. For instance, elastomeric pumps are widely used in outpatient parenteral antibiotic therapy (OPAT), as they provide portable, non-electronic infusion without the need for external power sources or complex tubing systems. A notable example is the SMARTeZ(R) disposable elastomeric pump developed by Progressive Medical, Inc., designed for both intermittent and continuous antibiotic infusion as well as general infusion therapies.

Technological advancements in elastomeric pump design have significantly enhanced their usability, durability, and safety. These innovations have led to the development of pumps with extended drug stability and storage capabilities, enabling them to be refrigerated or even frozen without compromising performance. One of the key benefits of these advanced devices is the incorporation of pre-set flow rates, which help minimize the risk of incorrect dosing, a common concern with electronic infusion pumps.

Furthermore, continuous elastomeric pumps are self-powered through an internal elastic balloon, eliminating the need for batteries or external power sources. Their low-maintenance design reduces the likelihood of mechanical failure, making them highly reliable. These features, combined with their portability and ease of use, make these pumps suitable for a wide range of clinical settings.

Thus, the factors mentioned above are likely to boost the market segment and thereby increase the overall market of elastomeric pump across the globe.

North America is expected to dominate the overall elastomeric pump market:

North America is projected to hold the largest share of the elastomeric pump market in 2024, driven by several key factors. This regional dominance is primarily attributed to the rising prevalence of chronic diseases, a highly advanced healthcare infrastructure, and the strong presence of key market players. Collectively, these factors are positioning North America as the leading market in the global elastomeric pump market.

According to data from the International Agency for Research on Cancer (2025), the number of new cancer cases in the U.S. was 2,380,189 in 2022, with projections indicating a significant rise to 3,380,124 cases by 2045. Among these, leukemia had 63,100 new cases in 2022, expected to increase to 88,600 by 2045. Similarly, data from the Canadian Cancer Society (2024), over 6,600 people were diagnosed with leukemia in Canada. Cancer treatments often require continuous delivery of chemotherapy, targeted therapies, and immunotherapy, making elastomeric infusion pumps an essential tool in oncology care.

According to the American Heart Association (2024), more than 29.3 million adults have been diagnosed with diabetes, while an estimated 9.7 million remain undiagnosed. Furthermore, 115.9 million Americans were reported to be living with pre-diabetes as of 2021. Elastomeric pumps play a critical role in insulin therapy by delivering precise and continuous doses needed to maintain stable blood glucose levels, particularly in patients requiring intensive insulin regimens.

Furthermore, as per the Centers for Disease Control and Prevention (2023), approximately 20.9% of adults, or 51.6 million people, experienced chronic pain in 2022. Of these, 6.9% (17.1 million people) suffered from high-impact chronic pain that significantly limits daily activities. Elastomeric pumps, often used for continuous infusion of pain-relieving medications, are increasingly being adopted in pain management strategies, especially for patients dealing with long-term, non-cancer-related pain.

Additionally, as per the data provided by the U.S Department of Health and Human Services (2023), it was stated that about 23 million Americans visit a doctor's office or clinic seeking treatment for infections every year.

In addition to the growing disease burden, North America benefits from an advanced healthcare infrastructure, which supports the widespread adoption of advanced infusion technologies. The presence of leading medical device manufacturers and key market players further strengthens the region's position in the global elastomeric pump market.

Collectively, these factors, such as rising chronic disease prevalence, strong clinical demand, and robust healthcare infrastructure, are expected to significantly drive the growth of the North America elastomeric pump market during the forecast period.

Elastomeric Pump Market Key Players:

Some of the key market players operating in the elastomeric pump market include B.Braun Melsungen AG, Baxter, Nipro Corporation, DAIKEN MEDICAL CO., LTD., Gamastech Innovative Infusion Systems, Vikymed Italia srl, PAJUNK, Ace Medical, McKesson Corporation, MULTIMEDICAL S.r.l., Progressive Medical, Inc., Vygon Group, Promecon GmbH, Preferred Medical, Adriamed SRL, FLOWONIX MEDICAL INC., Smiths Group plc, Fresenius SE & Co. KGaA, Avanos Medical, Inc., Intera Oncology, and others.

Recent Developmental Activities in the Elastomeric Pump Market:

  • In May 2024, Arecor Therapeutics plc announced a research collaboration with Medtronic to develop a novel, high-concentration, thermostable insulin for use in a next-generation pump. Through this collaboration, both companies bring advancements in insulin treatment to enhance patient care by providing insulin that reduces the need for pump maintenance interventions. This could broaden its utility for physicians and lead to significant healthcare cost savings.

Key takeaways from the elastomeric pump market report study

  • Market size analysis for the current elastomeric pump market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the elastomeric pump market.
  • Various opportunities available for the other competitors in the elastomeric pump market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current elastomeric pump market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the elastomeric pump market growth in the future?

Target audience who can benefit from this elastomeric pump market report study

  • Elastomeric pump product providers
  • Research organizations and consulting companies
  • Elastomeric pump-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in elastomeric pumps
  • Various end-users who want to know more about the elastomeric pump market and the latest technological developments in the elastomeric pump market.

Frequently Asked Questions for the Elastomeric Pump Market:

1. What is an elastomeric pump?

  • Elastomeric pump, also known as a balloon pump or elastomeric infusion pump, is a non-electronic, disposable medical device used to deliver continuous, controlled volumes of medication to a patient over a set period of time.

2. What is the market for an elastomeric pump?

  • The elastomeric pump market was valued at USD 663.39 million in 2024, growing at a CAGR of 6.72% during the forecast period from 2025 to 2032 to reach USD 1,109.14 million by 2032.

3. What are the drivers for the elastomeric pump market?

  • The demand for elastomeric pumps is growing due to several key factors. These include the increasing prevalence of chronic diseases such as cancer, diabetes, and neurological conditions, and others. There is also a rising shift toward home healthcare, as these pumps allow patients to receive infusion therapy at home. Additionally, ongoing technological advancements in product development are enhancing the effectiveness and convenience of these devices. Together, these factors are creating a strong foundation for steady and robust growth in the elastomeric pump market from 2025 to 2032.

4. Who are the key players operating in the elastomeric pump market?

  • Some of the key market players operating in the elastomeric pump market include B.Braun Melsungen AG, Baxter, Nipro Corporation, DAIKEN MEDICAL CO., LTD., Gamastech Innovative Infusion Systems, Vikymed Italia srl, PAJUNK, Ace Medical, McKesson Corporation, MULTIMEDICAL S.r.l., Progressive Medical, Inc., Vygon Group, Promecon GmbH, Preferred Medical, Adriamed SRL, FLOWONIX MEDICAL INC., Smiths Group plc, Fresenius SE & Co. KGaA, Avanos Medical, Inc., Intera Oncology, and others.

5. Which region has the highest share in the elastomeric pump market?

  • North America is projected to hold the largest share of the elastomeric pump market in 2024, driven by several key factors. This regional dominance is primarily attributed to the rising prevalence of chronic diseases, a highly advanced healthcare infrastructure, and the strong presence of key market players. Collectively, these factors are positioning North America as the leading market in the global elastomeric pump market.

Table of Contents

1. Elastomeric Pump Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Elastomeric Pump Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Elastomeric Pump Market Key Factors Analysis

  • 5.1. Elastomeric Pump Market Drivers
    • 5.1.1. The growing prevalence of chronic diseases
    • 5.1.2. Increasing number of surgical procedures in healthcare
    • 5.1.3. Technological advancements in product development
  • 5.2. Elastomeric Pump Market Restraints and Challenges
    • 5.2.1. Limitations and challenges associated with elastomeric pumps
    • 5.2.2. Stringent regulatory requirements for device approval
  • 5.3. Elastomeric Pump Market Opportunity
    • 5.3.1. Improvements in product design for developing precision during drug delivery
    • 5.3.2. Increasing expansion of home-based elastomeric pumps

6. Elastomeric Pump Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Elastomeric Pump Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Continuous Rate Elastomeric Infusion Pumps
    • 7.1.2. Variable Rate Elastomeric Infusion Pumps
    • 7.1.3. Both
  • 7.2. By Route of Administration
    • 7.2.1. Intravenous
    • 7.2.2. Subcutaneous
    • 7.2.3. Epidural
    • 7.2.4. Others
  • 7.3. By Indication
    • 7.3.1. Pain Management
    • 7.3.2. Antibiotic Therapy
    • 7.3.3. Chemotherapy
    • 7.3.4. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Homecare Settings
    • 7.4.4. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.1.2. Canada Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.1.3. Mexico Elastomeric Pump Market Size in USD million (2022-2032)
    • 7.5.2. Europe
      • 7.5.2.1. France Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.2.2. Germany Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.2.3. United Kingdom Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.2.4. Italy Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.2.5. Spain Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.2.6. Rest of Europe Elastomeric Pump Market Size in USD million (2022-2032)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.3.2. Japan Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.3.3. India Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.3.4. Australia Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.3.5. South Korea Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.3.6. Rest of Asia-Pacific Elastomeric Pump Market Size in USD million (2022-2032)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.4.2. Africa Elastomeric Pump Market Size in USD million (2022-2032)
      • 7.5.4.3. South America Elastomeric Pump Market Size In USD Million (2022-2032)

8. Elastomeric Pump Market Company and Product Profiles

  • 8.1. B.Braun Melsungen AG
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Baxter
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Nipro Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. DAIKEN MEDICAL CO., LTD.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Gamastech Innovative Infusion Systems
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Vikymed Italia srl
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. PAJUNK
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Ace Medical
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. McKesson Corporation
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. MULTIMEDICAL S.r.l.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Progressive Medical, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Vygon Group
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Promecon GmbH
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Preferred Medical
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Adriamed SRL
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. FLOWONIX MEDICAL INC.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Smiths Group plc
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Fresenius SE & Co. KGaA.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Avanos Medical, Inc.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Intera Oncology
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Elastomeric Pump Market in Global (2022-2032)
  • Table 3: Elastomeric Pump Market in Global by Product Type (2022-2032)
  • Table 4: Elastomeric Pump Market in Global by Route of Administration (2022-2032)
  • Table 5: Elastomeric Pump Market in Global by Indication (2022-2032)
  • Table 6: Elastomeric Pump Market in Global by End-User (2022-2032)
  • Table 7: Elastomeric Pump Market in Global by Geography (2022-2032)
  • Table 8: Elastomeric Pump Market in North America (2022-2032)
  • Table 9: Elastomeric Pump Market in the United States (2022-2032)
  • Table 10: Elastomeric Pump Market in Canada (2022-2032)
  • Table 11: Elastomeric Pump Market in Mexico (2022-2032)
  • Table 12: Elastomeric Pump Market in Europe (2022-2032)
  • Table 13: Elastomeric Pump Market in France (2022-2032)
  • Table 14: Elastomeric Pump Market in Germany (2022-2032)
  • Table 15: Elastomeric Pump Market in United Kingdom (2022-2032)
  • Table 16: Elastomeric Pump Market in Italy (2022-2032)
  • Table 17: Elastomeric Pump Market in Spain (2022-2032)
  • Table 18: Elastomeric Pump Market in the Rest of Europe (2022-2032)
  • Table 19: Elastomeric Pump Market in Asia-Pacific (2022-2032)
  • Table 20: Elastomeric Pump Market in China (2022-2032)
  • Table 21: Elastomeric Pump Market in Japan (2022-2032)
  • Table 22: Elastomeric Pump Market in India (2022-2032)
  • Table 23: Elastomeric Pump Market in Australia (2022-2032)
  • Table 24: Elastomeric Pump Market in South Korea (2022-2032)
  • Table 25: Elastomeric Pump Market in Rest of Asia-Pacific (2022-2032)
  • Table 26: Elastomeric Pump Market in the Rest of the World (2022-2032)
  • Table 27: Elastomeric Pump Market in the Middle East (2022-2032)
  • Table 28: Elastomeric Pump Market in Africa (2022-2032)
  • Table 29: Elastomeric Pump Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Elastomeric Pump Market in Global (2022-2032)
  • Figure 3: Elastomeric Pump Market in Global by Product Type (2022-2032)
  • Figure 4: Elastomeric Pump Market in Global by Route of Administration (2022-2032)
  • Figure 5: Elastomeric Pump Market in Global by Indication (2022-2032)
  • Figure 6: Elastomeric Pump Market in Global by End-User (2022-2032)
  • Figure 7: Elastomeric Pump Market in Global by Geography (2022-2032)
  • Figure 8: Elastomeric Pump Market in North America (2022-2032)
  • Figure 9: Elastomeric Pump Market in the United States (2022-2032)
  • Figure 10: Elastomeric Pump Market in Canada (2022-2032)
  • Figure 11: Elastomeric Pump Market in Mexico (2022-2032)
  • Figure 12: Elastomeric Pump Market in Europe (2022-2032)
  • Figure 13: Elastomeric Pump Market in France (2022-2032)
  • Figure 14: Elastomeric Pump Market in Germany (2022-2032)
  • Figure 15: Elastomeric Pump Market in United Kingdom (2022-2032)
  • Figure 16: Elastomeric Pump Market in Italy (2022-2032)
  • Figure 17: Elastomeric Pump Market in Spain (2022-2032)
  • Figure 18: Elastomeric Pump Market in the Rest of Europe (2022-2032)
  • Figure 19: Elastomeric Pump Market in Asia-Pacific (2022-2032)
  • Figure 20: Elastomeric Pump Market in China (2022-2032)
  • Figure 21: Elastomeric Pump Market in Japan (2022-2032)
  • Figure 22: Elastomeric Pump Market in India (2022-2032)
  • Figure 23: Elastomeric Pump Market in Australia (2022-2032)
  • Figure 24: Elastomeric Pump Market in South Korea (2022-2032)
  • Figure 25: Elastomeric Pump Market in Rest of Asia-Pacific (2022-2032)
  • Figure 26: Elastomeric Pump Market in the Rest of the World (2022-2032)
  • Figure 27: Elastomeric Pump Market in the Middle East (2022-2032)
  • Figure 28: Elastomeric Pump Market in Africa (2022-2032)
  • Figure 29: Elastomeric Pump Market in South America (2022-2032)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis